Skip to main content
. 2023 Dec 20;18(12):e0294861. doi: 10.1371/journal.pone.0294861

Table 1. Comparison of baseline characteristics of the included population.

Variables Overall (n* = 31,184) Non-CHD (n = 29,580) CHD (n = 1,604) P-value
Age (years), Median (IQR) 49.00 (36.00, 61.00) 48.00 (36.00, 60.00) 68.00 (60.00, 76.00) < 0.001
Age (years), n (%) < 0.001
 20–44 years 11,315 (40.62) 11,267 (42.19) 48 (4.40)
 45–64 years 11,352 (39.39) 10,887 (39.65) 465 (33.54)
 ≥ 65 years 8,517 (19.98) 7,426 (18.16) 1,091 (62.05)
Sex, n (%) < 0.001
 Male 15,336 (48.33) 14,214 (47.53) 1,122 (67.00)
 Female 15,848 (51.67) 15,366 (52.47) 482 (33.00)
Marital status, n (%) 0.620
 Married or living with a partner 19,271 (66.22) 18,278 (66.25) 993 (65.49)
 Living alone 11,913 (33.78) 11,302 (33.75) 611 (34.51)
Race/ethnicity, n (%) < 0.001
 Non-Hispanic white 4,150 (6.25) 4,009 (6.39) 141 (2.87)
 Non-Hispanic black 2,452 (4.76) 2,363 (4.86) 89 (2.60)
 Mexican American 15,205 (72.62) 14,125 (72.16) 1,080 (83.41)
 Other 9,377 (16.37) 9,083 (16.59) 294 (11.11)
Education level, n (%) < 0.001
 Below high school 6,696 (13.44) 6,211 (13.02) 485 (23.11)
 High school 7,089 (22.91) 6,701 (22.76) 388 (26.36)
 Above high school 17,399 (63.65) 16,668 (64.22) 731 (50.53)
PIR, n (%) 0.813
 ≥ 1 25,787 (88.52) 24,456 (88.51) 1,331 (88.73)
 < 1 5,397 (11.48) 5,124 (11.49) 273 (11.27)
BMI (kg/m2), n (%) < 0.001
 Normal weight 9,244 (30.81) 8,836 (31.14) 408 (23.23)
 Low weight 405 (1.37) 389 (1.39) 16 (0.79)
 Overweight 10,849 (34.65) 10,259 (34.60) 590 (35.75)
 Obesity 10,686 (33.17) 10,096 (32.87) 590 (40.23)
Smoking, n (%) < 0.001
 No 16,828 (54.48) 16,264 (55.35) 564 (34.41)
 Yes 14,356 (45.52) 13,316 (44.65) 1,040 (65.59)
Stroke, n (%) < 0.001
 No 29,853 (96.95) 28,502 (97.44) 1,351 (85.53)
 Yes 1,331 (3.05) 1,078 (2.56) 253 (14.47)
Hypertension, n (%) < 0.001
 No 18,804 (65.46) 18,400 (67.11) 404 (27.46)
 Yes 12,380 (34.54) 11,180 (32.89) 1,200 (72.54)
Hyperlipidemia, n (%) < 0.001
 No 18,942 (62.51) 18,497 (64.09) 445 (25.84)
 Yes 12,242 (37.49) 11,083 (35.91) 1,159 (74.16)
Diabetes, n (%) < 0.001
 No 26,874 (89.95) 25,817 (90.90) 1,057 (68.02)
 Yes 4,310 (10.05) 3,763 (9.10) 547 (31.98)
Supplements taken, n (%) < 0.001
 No 17,047 (57.49) 16,028 (57.14) 1,019 (65.60)
 Yes 14,137 (42.51) 13,552 (42.86) 585 (34.40)
Alcohol (g/d), Median (IQR) 0.00 (0.00, 9.35) 0.00 (0.00, 9.35) 0.00 (0.00, 3.25) < 0.001
HDL-C (mmol/L), Median (IQR) 1.32 (1.09, 1.60) 1.32 (1.09, 1.63) 1.16 (0.98, 1.45) < 0.001
TC (mmol/L), Median (IQR) 5.02 (4.34, 5.74) 5.04 (4.37, 5.74) 4.40 (3.75, 5.20) < 0.001
ALA (g/d), Median (IQR) 1.36 (0.91, 2.00) 1.37 (0.92, 2.01) 1.27 (0.85, 1.89) < 0.001
DPA (g/d), Median (IQR) 0.01 (0.01, 0.03) 0.01 (0.01, 0.03) 0.01 (0.00, 0.02) 0.017
ETA (g/d), Median (IQR) 0.12 (0.07, 0.19) 0.12 (0.07, 0.19) 0.11 (0.06, 0.18) 0.001
EPA (g/d), Median (IQR) 0.01 (0.00, 0.02) 0.01 (0.00, 0.02) 0.01 (0.00, 0.02) 0.990
DHA (g/d), Median (IQR) 0.03 (0.01, 0.06) 0.03 (0.01, 0.06) 0.02 (0.01, 0.06) 0.633
Omega-3 (g/d), Median (IQR) 1.62 (1.10, 2.35) 1.62 (1.10, 2.36) 1.52 (1.03, 2.26) < 0.001

Abbreviations: CHD, coronary heart disease; IQR, interquartile range; PIR, poverty income ratio; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; ALA, α-linolenic acid; DPA, docosapentaenoic acid; ETA, eicosatetraenoic acid; EPA, eicosapentaenoic acid; DHA, docosahexenoic acid.

* n is unweighted, percentages and median (IQR) are weighted, and P-values are calculated from the weighted data.